NDC11 51167033101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 51167-0331-01 | 51167-0331 |
| 51167-0331-1 | 51167-0331 |
| 51167-331-01 | 51167-331 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trikafta | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | Vertex Pharmaceuticals Incorporated | f354423a-85c2-41c3-a9db-0f3aee135d8d | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | 51167-331-01 51167-331 51167033101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.